HomeInvestors HealthI-Mab Biopharma 1H Earnings Preview

I-Mab Biopharma 1H Earnings Preview

1724784077_og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png

August 27, 2024

I-Mab Biopharma (NASDAQ:IMAB) is scheduled to announce 1H earnings results on Wednesday, August 28th, before market open.
The consensus EPS Estimate is -$0.55 (+47.6% Y/Y) and the consensus Revenue Estimate is $0.75M (-72.2% Y/Y).
Over the last 1 year, IMAB has beaten EPS estimates 0% of the time and has beaten revenue estimates 25% of the time.

Previous article

Home Construction Is Undergoing a Revolution. Here’s How Investors Will Benefit.

Next article

Should You Buy Apple Stock Before September 9? Here’s What the Evidence Suggests

Investors Health Image

latest articles

explore more

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here